Editor's Note
The Food & Drug Administration (FDA) on July 22 issued a final guidance for makers of products that combine devices and drugs or biologics.
The guidance clarifies how manufacturers should comply with recordkeeping requirements and how they should submit safety reports and avoid duplication.
Robotic surgery has moved from cutting-edge to commonplace. The question…
Office-based surgery (OBS) is one of the fastest-growing care settings…
Stress and burnout are more than workforce concerns; they are…